Article
Mohammadi Ziarani et al.
[1,2-b]phthalazine-2-carbonitrile 4b: M.p = 266-268 °C; IR
(KBr): 3375, 3264, 2200, 1662, 1655 cm-1; 1H NMR (300 MHz,
DMSO-d6): d 6.15 (s, 1H), 7.41-7.53 (m, 4H), 7.93-8.26 (m, 4H),
8.13 (s, 2H); 13C NMR (75 MHz, DMSO-d6): d 61.3, 62.7, 116.4,
127.1, 127.7, 128.9, 129.3, 133.3, 134.2, 135.1, 137.9, 151.2,
154.1, 157.1; MS: m/z: 350 (M+). 3-Amino-1-(2,3-dichloro-
phenyl)-5,10-dihydro-5,10-dioxo-1H-pyrazolo[1,2-b]phthal-
azine-2-carbonitrile 4c: M.p = 282-284 °C; IR (KBr): 3162,
DMSO-d6): d 1.03 (t, J = 6.8 Hz, 3H), 3.95 (q, J = 6.7 Hz, 2H),
6.18 (s, 1H), 7.73-8.29 (m, 10H); 13C NMR (75 MHz, DMSO-d6):
d 14.6, 59.2, 63.0, 81.1, 123.5, 125.5, 127.1, 127.7, 129.0, 129.2,
133.0, 134.2, 135.1, 147.3, 147.7, 153.8, 157.3, 164.2; MS: m/z:
408 (M+). Ethyl 3-amino-1-(3-nitrophenyl)-5,10-dihydro-
5,10- dioxo-1H-pyrazolo[1,2-b]phthalazine-2-carboxylate 4i:
M.p = 236-238 °C; IR (KBr): 3360, 3249, 1693, 1651, 1613 cm-1;
1H NMR (300 MHz, DMSO-d6): d 0.99 (t, J = 9.2 Hz, 3H), 3.94
(q, J = 7.8 Hz, 2H), 6.22 (s, 1H), 7.56-8.30 (m, 10H); 13C NMR
(75 MHz, DMSO-d6): d14.5, 59.1, 63.1, 81.1, 122.5, 123.1,
127.1, 127.6, 129.0, 129.4, 129.9, 134.1, 134.5, 135.0, 142.6,
147.9, 150.5, 153.9, 157.3, 164.3; MS: m/z: 408 (M+).
1
3017, 2895, 2581, 2226, 1660, 1580, 1492, 822 cm-1; H NMR
(250 MHz, CDCl3): d 6.52 (s, 1H), 6.75 (s, 2H), 7.30-7.61 (m,
3H), 8.16-8.28 (m, 4H); 13C NMR (300 MHz, DMSO-d6): d 59.2,
60.9, 115.5, 125.1, 126.7, 127.3, 128.2, 128.8, 129.3, 130.3,
132.0, 132.5, 133.9, 134.7, 138.0, 151.2, 153.6, 156.6; MS: m/z:
384 (M+). 3-Amino-1-(2,4-dichlorophenyl)-5,10-dihydro-5,10-
dioxo-1H-pyrazolo[1,2-b]phthalazine-2-carbonitrile 4d: M.p
= 242-244 °C; IR (KBr): 3370, 3232, 3172, 2896, 2209, 1660,
1562, 1493, 824 cm-1; 1H NMR (250 MHz, CDCl3): d 6.53 (s, 1H),
6.74 (s, 2H), 7.29-7.61 (m, 3H), 8.16-8.28 (m, 4H); 13C NMR
(300 MHz, DMSO-d6): d 56.0, 59.2, 115.5, 126.7, 127.3, 128.0,
128.2, 128.8, 129.1, 130.4, 132.3, 133.6, 133.9, 134.4, 134.7,
151.1, 153.5, 156.6; MS: m/z: 384 (M+). 3-Amino-1-(4-methoxy-
phenyl)-5,10-dihydro-5,10-dioxo-1H-pyrazolo[1,2-b]phthal-
azine-2-carbonitrile 4e: M.p = 270 °C (dec.); IR (KBr): 3016,
2895, 2220, 1660, 1555, 825 cm-1; 1H NMR (250 MHz, CDCl3): d
3.94 (s, 3H), 6.23 (s, 1H), 7.03-7.29 (m, 4H), 7.68-7.95 (m, 5H);
13C NMR (300 MHz, DMSO-d6): d 55.8, 61.8, 76.8, 113.8, 114.8,
115.1, 124.0, 125.1, 125.4, 127.1, 132.5, 133.3, 154.6, 160.3,
164.3; MS: m/z: 346 (M+). 3-Amino-1-(3-methoxyphenyl)-
5,10-dihydro-5,10-dioxo-1H-pyrazolo[1,2-b]phthalazine-2-
carbonitrile 4f: M.p = 264-266 °C; IR (KBr): 3011, 2897, 2227,
1661, 1598, 1571, 1493, 952 cm-1; 1H NMR (250 MHz, CDCl3): d
3.84 (s, 3H), 6.10 (s, 1H), 6.22-7.06 (m, 4H), 7.29-7.55 (m, 4H),
8.30 (s, 2H); 13C NMR (300 MHz, DMSO-d6): d 56.2, 58.8, 59.0,
111.5, 121.4, 121.6, 122.0, 122.2, 123.8, 124.3, 124.6, 127.2,
132.6, 154.6, 158.2, 160.9; MS: m/z: 346 (M+). Ethyl 3-amino-
1-(p-tolyl)-5,10-dihydro-5,10-dioxo-1H-pyrazolo[1,2-b]phth-
alazine-2-carboxylate 4g: M.p = 201-203 °C; IR (KBr): 3447,
3333, 1706, 1658, 1624 cm-1; 1H NMR (300 MHz, DMSO-d6): d
1.04 (t, J = 8.9 Hz, 3H), 2.25 (s, 3H), 3.96 (q, J = 9.0 Hz, 2H), 6.04
ACKNOWLEDGEMENTS
We gratefully acknowledge for the financial support
from the Research Council of Alzahra University and the
University of Tehran.
REFERENCES
1. Wight, A. P.; Davis, M. E. Chem. Rev. 2002, 102, 3589.
2. Lai, Z.; Bonilla, G.; Diaz, I.; Nery, J. G.; Sujaoti, K.; Amat,
M. A.; Kokkoli, E.; Terasaki, O.; Thompson, R. W.; Tsapatsis,
M.; Vlachos, D. G. Science 2003, 300, 456.
3. Walcarius, A. Chem. Mater. 2001, 13, 3351.
4. Sanchez, C.; Lebeau, B.; Chaput, F.; Boilot, J. P. Adv. Mater.
2003, 15, 1969.
5. Song, S. W.; Hidajat, K.; Kawi, S. Langmuir 2005, 21, 9568.
6. Han, Y.-J.; Stucky, G. D.; Butler, A. J. Am. Chem. Soc. 1999,
121, 9897.
7. Srinivas, D.; Saikia, L. Catal. Surv. Asia 2008, 12, 114.
8. Karimi, B.; Vafaeezadeh, M. Chem. Commun. 2012, 48,
3327.
9. Çitak, A.; Erdem, B.; Erdem, S.; Öksüzolu, R. M. J.
Colloid. Interface Sci. 2012, 369, 160.
10. Jain, R. P.; Vederas, J. C. Bioorg. Med. Chem. Lett. 2004, 14,
3655.
11. Grasso, S.; De Sarro, G.; De Sarro, A.; Micale, N.; Zappalà,
M.; Puja, G.; Baraldi, M.; De Micheli, C. J. Med. Chem.
2000, 43, 2851.
12. Shah, N. M.; Patel, M. P.; Patel, R. G. J. Heterocycl. Chem.
2012, 49, 1310.
13. Al’-Assar, F.; Zelenin, K. N.; Lesiovskaya, E. E.; Bezhan, I.
P.; Chakchir, B. A. Pharm. Chem. J. 2002, 36, 598.
14. Ghahremanzadeh, R.; Imani Shakibaei, G.; Bazgir, A.
Synlett 2008, 1129.
(s, 1H), 7.07-7.38 (m, 4H), 7.69 (br s, 2H), 7.92-8.27 (m, 4H); 13
C
NMR (75 MHz, DMSO-d6): d 14.6, 21.1, 59.1, 63.4, 82.1, 127.1,
127.7, 128.9, 129.1, 129.3, 134.0, 135.1, 137.2, 137.2, 150.1,
153.4, 157.2, 164.5; MS: m/z: 377 (M+). Ethyl 3-amino-1-(4-
nitrophenyl)-5,10-dihydro-5,10-dioxo-1H-pyrazolo[1,2-b]-
phthalazine-2-carboxylate 4h: M.p = 239-241 °C; IR (KBr):
3386, 3210, 1694, 1655, 1630 cm-1; 1H NMR (300 MHz,
15. Nabid, M. R.; Rezaei, S. J. T.; Ghahremanzadeh, R.; Bazgir,
A. Ultrason. Sonochem. 2010, 17, 159.
16. Raghuvanshi, D. S.; Singh, K. N. Tetrahedron Lett. 2011, 52,
5702.
4
© 2014 The Chemical Society Located in Taipei & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
J. Chin. Chem. Soc. 2014, 61, 000-000